Cara Therapeutics, Inc. (CARA): Price and Financial Metrics
Cara Therapeutics, Inc. (CARA)
Today's Latest Price: $14.86 USD
Updated Oct 20 4:00pm
Add CARA to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
CARA Stock Summary
- Of note is the ratio of Cara Therapeutics Inc's sales and general administrative expense to its total operating expenses; only 6.43% of US stocks have a lower such ratio.
- For CARA, its debt to operating expenses ratio is greater than that reported by just 6.3% of US equities we're observing.
- CARA's price/sales ratio is 27.19; that's higher than the P/S ratio of 93.76% of US stocks.
- If you're looking for stocks that are quantitatively similar to Cara Therapeutics Inc, a group of peers worth examining would be ANAB, MORF, MGNX, PTGX, and VBLT.
- Visit CARA's SEC page to see the company's official filings. To visit the company's web site, go to www.caratherapeutics.com.
CARA Stock Price Chart Interactive Chart >
CARA Price/Volume Stats
| Current price | $14.86 | 52-week high | $26.67 |
| Prev. close | $13.93 | 52-week low | $8.88 |
| Day low | $14.14 | Volume | 903,800 |
| Day high | $15.23 | Avg. volume | 489,323 |
| 50-day MA | $14.76 | Dividend yield | N/A |
| 200-day MA | $15.41 | Market Cap | 696.74M |
Cara Therapeutics, Inc. (CARA) Company Bio
Cara Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors. The company was founded in 2004 and is based in Shelton, Connecticut.
Loading social stream, please wait...